Clinical Characteristics and Prognosis Analysis of Infantile Hepatoblastoma—A 15-Year Retrospective Single-Center Study

References

• Czauderna P, Garnier H. Hepatoblastoma: current understanding, recent advances, and controversies. F1000 Res. 2018;7:53. doi:10.12688/f1000research.12239.1
   PubMedGoogle Scholar
• Calvisi DF, Solinas A. Hepatoblastoma: current knowledge and promises from preclinical studies. Transl Gastroenterol Hepatol. 2020;5:42. doi:10.21037/tgh.2019.12.0332632393
   PubMed Web of Science ®Google Scholar
• Angela D, Trobaugh-Lotrario MD, Barbara H, et al. Outcomes for patients with congenital hepatoblastoma. Pediatr Blood Cancer. 2013;60(11):1817–1825. doi:10.1002/pbc.2465523798361
   PubMed Web of Science ®Google Scholar
• Haeberle B, Rangaswami A, Krailo M, et al. The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: analysis from the Children’s Hepatic tumors International Collaboration (CHIC) database. Pediatr Blood Cancer. 2020;67(8):e28350. doi:10.1002/pbc.2835032383794
   PubMed Web of Science ®Google Scholar
• Czauderna P, Lopez-Terrada D, Hiyama E, et al. Hepatoblastoma state of the art: pathology genetics, risk stratification, and chemotherapy. Curr Opin Pediatr. 2014;26(1):19–28. doi:10.1097/MOP.000000000000004624322718
   PubMed Web of Science ®Google Scholar
• Roebuck DJ, Aronson D, Clapuyt P, et al. International Childhood Liver Tumor Strategy Group 2005 PRETEXT: a revised staging system for primary malignant liver tumors of childhood developed by the SIOPEL group. Pediatr Radiol. 2007;37:123–132.17186233
   PubMed Web of Science ®Google Scholar
• Jiang YZ, Zhou SY, Shen G, et al. Microwave ablation combined with transcatheter arterial chemoembolization is effective for treating unresectable hepatoblastoma in infants and children. Medicine. 2018;97(42):e12607. doi:10.1097/MD.000000000001260730334945
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Sasaki F, Ohira M, et al. Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma. Pediatr Surg Int. 2003;19(3):142–146. doi:10.1007/s00383-002-0906-012768314
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang WL, Huang DS, et al. Clinical effectiveness of multimodality treatment on advanced pediatric hepatoblastoma. Eur Rev Med Pharmacol Sci. 2014;18(7):1018–1026.24763882
   PubMed Web of Science ®Google Scholar
• Hafberg E, Borinstein SC, Alexopoulos SP, et al. Contemporary management of hepatoblastoma. Curr Opin Organ Transplant. 2019;24(3):113–117. doi:10.1097/MOT.000000000000061830762666
   PubMed Web of Science ®Google Scholar
• Maruyama K, Ikeda H, Koizumil T, et al. Prenatal and postnatal histories of very low birthweight infants who developed hepatoblastoma. Pediatr Int. 1999;41(1):82–89. doi:10.1046/j.1442-200x.1999.01022.x10200142
   PubMed Web of Science ®Google Scholar
• Heck JE, Meyers TJ, Lombardi C, et al. Case-control study of birth characteristics and the risk of hepatoblastoma. Cancer Epidemiol. 2013;37(4):390–395. doi:10.1016/j.canep.2013.03.00423558166
   PubMed Web of Science ®Google Scholar
• Johnson KJ, Carozza SE, Chow EJ, et al. Parental age and risk of childhood cancer: a pooled analysis. Epidemiology. 2009;20:475–483. doi:10.1097/EDE.0b013e3181a5a332
   Web of Science ®Google Scholar
• Zhang Y, Zhang W, Tang S, et al. A single-center retrospective study of pediatric hepatoblastoma. Oncol Lett. 2016;12(5):3919–3925. doi:10.3892/ol.2016.519527895749
   PubMed Web of Science ®Google Scholar
• Zhao W, Li J, Zhang J, et al. Detection of serum protein biomarkers for the diagnosis and staging of hepatoblastoma. Int J Mol Sci. 2015;16(6):12669–12685. doi:10.3390/ijms16061266926053398
   PubMed Web of Science ®Google Scholar
• Yhoshu E, Lone YA, Mahajan JK, et al. Hepatoblastoma with precocious puberty. Indian Assoc Pediatr Surg. 2019;24(1):68–71. doi:10.4103/jiaps.JIAPS_102_18
   PubMedGoogle Scholar
• Malati T. Clinical relevance of AFP, its molecular variants and hCG in hepatoblastoma and childhood germ cell tumors. Clin Biochem. 2014;47:734. doi:10.1016/j.clinbiochem.2014.05.03524854689
   PubMed Web of Science ®Google Scholar
• Malogolowkin MH, Katzenstein HM, Meyers RL, et al. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the children’s oncology group. J Clin Oncol. 2011;29(24):3301–3306. doi:10.1200/JCO.2010.29.383721768450
   PubMed Web of Science ®Google Scholar
• Trobaugh-Lotrario AD, Tomlinson GE, Finegold MJ, et al. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer. 2009;52(3):328–334. doi:10.1002/pbc.2183418985717
   PubMed Web of Science ®Google Scholar
• Maibach R, Roebuck D, Brugieres L, et al. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience. Eur J Cancer. 2012;48:1543–1549. doi:10.1016/j.ejca.2011.12.01122244829
   PubMed Web of Science ®Google Scholar
• Angelico R, Grimaldi C, Gazia C, et al. How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature. Cancers. 2019;11(11). doi:10.3390/cancers11111693.
   PubMed Web of Science ®Google Scholar
• Lake CM, Tiao GM, Bondoc AJ, et al. Surgical management of locally-advanced and metastatic hepatoblastoma. Semin Pediatr Surg. 2019;28(6):150856. doi:10.1016/j.sempedsurg.2019.15085631931965
   PubMed Web of Science ®Google Scholar
• Shanmugam N, Scott JX, Kumar V, et al. Multidisciplinary management of hepatoblastoma in children: experience from a developing country. Pediatr Blood Cancer. 2017; 3. doi:10.1002/pbc.26249
   Web of Science ®Google Scholar
• Marin JJG, Cives-Losada C, Asensio M, et al. Mechanisms of anticancer drug resistance in hepatoblastoma. Cancers. 2019;11(3):407. doi:10.3390/cancers11030407
   PubMed Web of Science ®Google Scholar
• Yoshinari M, Imaizumi M, Hayashi Y, et al. Peripheral blood stem cell transplantation for hepatoblastoma with microscopical residue: a therapeutic approach for incompletely resected tumor. Tohoku J Exp Med. 1998;184(3):247–254. doi:10.1620/tjem.184.2479591340
   PubMed Web of Science ®Google Scholar
• Lauferman L, Halac E, Aredes D, et al. Prognostic factors for event‐free survival in liver transplantation for hepatoblastoma: a single‐center experience. Pediatr Transplant. 2019;23(8):e13581. doi:10.1111/petr.1358131531932
   PubMed Web of Science ®Google Scholar